Claude

IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

IntuitionLabs
Back to Articles
IntuitionLabs

biotech eqms · trackwise vs mastercontrol

Biotech eQMS Comparison: TrackWise, MasterControl, Qualio

February 9, 2026
Updated October 6, 2026
45 min read

Evaluate TrackWise, MasterControl, Qualio, and QualityOne. Compare biotech eQMS features, FDA compliance, and scalability for startups to enterprises.

Biotech eQMS Comparison: TrackWise, MasterControl, Qualio
Summary
  1. 01TrackWise and MasterControl suit complex enterprise quality workflows. TrackWise emphasizes configurable multisite processes; MasterControl combines quality management with manufacturing execution.
  2. 02Qualio targets growing biotech and medtech firms with cloud delivery and an intuitive interface. Buyers should test required workflows and obtain a scoped implementation plan.
  3. 03QualityOne serves consumer packaged goods, food and beverage, and chemicals. Biopharma and MedTech buyers should assess Veeva Quality Cloud separately rather than transfer its capabilities to QualityOne.
  4. 04Regulatory compliance depends on intended use, configuration, supplier evidence, customer procedures, training and record controls. Software features alone do not establish compliance or guarantee audit acceptance.
  5. 05Vendor case studies describe results within named implementations. Fagron improvements and the Qualio customer milestones should remain tied to their reported scope, rather than treated as guarantees for future deployments.
01

Executive Summary

In the rapidly evolving biotech sector, electronic quality management systems (eQMS) have become indispensable tools for ensuring regulatory compliance, product safety, and operational efficiency. Biotech organizations – from small research startups to multinational pharmaceutical and medical device manufacturers – rely on eQMS platforms to manage documentation, training, CAPA (Corrective and Preventive Actions), audits, and other quality processes. This report provides a detailed evaluation of three life-sciences eQMS comparators and one adjacent-industry quality platform – TrackWise (Sparta/Honeywell), MasterControl, Qualio, and QualityOne (Veeva) – focusing on their features, use cases, strengths, and weaknesses in the biotech context. Key distinctions emerge: TrackWise is a venerable, enterprise-grade QMS with both on-premise and cloud (Salesforce-based) editions and pioneering AI-assisted quality analytics ([1]); MasterControl offers a highly integrated QMS/ MES platform trusted by over 1,100 life-sciences customers ([2]), emphasizing configurability and compliance automation ([3]) ([4]); Qualio is a modern cloud-native eQMS tailored to small-to-mid biotech/medtech firms, noted for rapid deployment and ease-of-use ([5]) ([6]); and QualityOne is Veeva’s adjacent-industry quality platform for consumer packaged goods, food and beverage, and chemicals Quality Management Solutions — Veeva QualityOne. Veeva separately positions Quality Cloud for biopharma, MedTech, and contract manufacturing. QualityOne is included here as a contextual comparator; its features and integrations should not be inferred from Quality Cloud documentation. Table 1 below summarizes the comparison.

  • TrackWise (Honeywell) – Established as one of the world’s most widely deployed eQMS platforms ([7]), TrackWise provides both on-premise and cloud (Salesforce) versions. It is designed for large, complex organizations (e.g. major pharma and device firms) that need highly configurable workflows, robust CAPA/complaint management, audit support, and AI-driven analytics (spartan systems claim it was the first QMS with embedded AI) ([1]) ([8]). Its strengths lie in quality workflows for regulated operations and integration with manufacturing data; its challenges include implementation and assurance work and a learning curve that limits use to quality specialists ([9]) ([10]).
  • MasterControl – A mature eQMS/MES suite (Quality Excellence) serving life-sciences and other regulated industries, MasterControl emphasizes end-to-end digital quality from R&D to manufacturing. About 1,100+ customers (pharma, biotech, device companies) use it to automate document control, CAPA, training and change management ([2]) ([11]). The cited comparisons describe workflows, analytics and connections to systems like ERP/ LIMS ([12]) ([13]). However, implementing MasterControl is a significant project (requiring an assurance plan for the intended use) and its form-based UI can feel restrictive for casual users ([10]). In its Fagron case study, MasterControl reports a 100% improvement in right-first-time metrics and a 50% reduction in deviation times at implemented manufacturing facilities. The case describes rollout in several U.S. sites and seven European sites; the results are not an absolute 100% yield or a demonstrated outcome across all 66 Fagron locations.
  • Qualio – A cloud-native eQMS launched for growing life-sciences companies. Qualio’s focus is on usability and speed of implementation – for example, 30 Technology’s testimonial describes going live in mid-December and receiving ISO 13485 certification by July ([5]). It covers core QMS functions (document control, CAPA, training, simple audit mgmt) and offers compliance-supporting workflows. Buyers should assess ISO 13485, FDA 21 CFR 11 and GxP requirements for their own processes and records rather than infer compliance from the software Part 11, Electronic Records; Electronic Signatures — Scope and Application — FDA. Qualio’s typical users are small medtech and biotech firms (the company cites ~650 life-science customers worldwide ([14])). The platform’s pros include an intuitive interface, rapid rollout, and strong support ([6]) ([15]).
  • QualityOne (Veeva) – Veeva documents QualityOne for consumer packaged goods, food and beverage, and chemicals Quality Management Solutions — Veeva QualityOne. Its applications connect quality assurance, food safety, controlled documentation, training, and lab workflows. It is a contextual comparator for manufacturers in those industries; Veeva Quality Cloud is the separately positioned life-sciences offering. Confirm the selected applications and intended use before evaluating regulatory support.

This report synthesizes these vendors’ capabilities and contextual factors – including market trends, regulatory changes, comparative case studies, and user feedback – to guide biotech organizations in choosing the most suitable eQMS. We compare features in Table 1 below and provide in-depth evaluations in subsequent sections.

T.01
Criteria / SoftwareTrackWise (Honeywell)MasterControl (MasterControl Inc.)QualioQualityOne (Veeva)
DeploymentSaaS (Salesforce) + On-Prem ([16])SaaS & On-Prem (cloud hosted options)Cloud-only SaaSCloud (Veeva Vault platform)
Primary FocusLarge pharma/biologics & medical devicesLife sciences (pharma/medical/devices)Small–mid biotech & medtechConsumer packaged goods, food and beverage, chemicals Quality Management Solutions — Veeva QualityOne
Typical Customers“Most widely used” QMS ([7]) (e.g. big pharma)1,100+ (startups to global enterprises) ([2])~650+ (growing life-science companies) ([14])Global manufacturers in QualityOne’s documented industries ([17])
Regulatory AssessmentAssess applicable record controls, workflows and intended useAssess applicable record controls, workflows and intended useAssess applicable record controls, workflows and intended useAssess requirements for QualityOne’s documented industries; do not infer medical-device compliance from QMSR
Key CapabilitiesDocument control, CAPA/NCR, deviations, change control, audit mgmt, supplier quality, AI insights ([1])Document control, CAPA/NCR, deviations, change control, training, audit mgmt, risk management, MES integration ([11]) ([12])Document control, CAPA, deviations, training, supplier mgmt; simpler UI/workflows ([18])Quality assurance, food safety, documentation, training and lab workflows Quality Management Solutions — Veeva QualityOne
Deployment PlanningObtain a scoped implementation planObtain a scoped implementation and assurance planVendor estimate: most prepared customers live in 30–60 days Qualio plans and pricingObtain an application- and site-specific implementation plan
Ease of UseModerate (designed for quality professionals; fixed workflows) ([9])Moderate (rich but form-driven UX; training needed) ([10])High (user-friendly, intuitive; web-driven) ([5]) ([15])Moderate (modern UI but broad scope; requires training)
AI / AnalyticsVendor-documented AI-assisted quality processes TrackWise AI for Life Sciences Quality Management — HoneywellVendor-documented Document Summarizer, Document Translator and Exam Generator MasterControl Announces General Availability of AI-Powered Document SummarizerAnnounced AI document editing, change summaries and training assessments Faster, streamlined quality processes powered by AI in QualioQualityOne-specific Vault AI documentation; confirm application and agent availability Quality Management Solutions — Veeva QualityOne
IntegrationSalesforce platform; integrates with SAP/ERP/LIMS via APIs ([8])Easy integration with ERP, CRM, MES, LIMS ([13]) ([19])Connectors to common SaaS tools (e.g. Slack, Office365); APIOpen APIs for ERP, PLM and MES; verify each integration’s scope Quality Management Solutions — Veeva QualityOne
Pricing AssessmentObtain a quote for the required scopeObtain a quote for the selected package MasterControl pricingTailored annual subscription; implementation fee applies; included edit users and unlimited basic users Qualio plans and pricingObtain a quote for the selected applications; applications are available separately Quality Management Solutions — Veeva QualityOne
Review EvidenceCheck platform, date and sample sizeCheck platform, date and sample sizeCheck platform, date and sample sizeCheck product identity, platform, date and sample size

Table 1. Feature and positioning comparison of three life-sciences eQMS comparators—TrackWise, MasterControl and Qualio—and the adjacent-industry comparator QualityOne.

Regulatory requirements belong to the applicable manufacturer and its processes; this table does not establish product compliance. Assess the intended use, configuration, assurance evidence, procedures, training and data-integrity controls against FDA QMSR where applicable and FDA’s Part 11 guidance for relevant electronic records.

$2.81B

DataIntelo estimate of the global life-sciences QMS market in 2024

$6.54B

DataIntelo forecast for the global life-sciences QMS market by 2033

100%

MasterControl vendor-reported improvement in Fagron right-first-time metrics at implemented facilities

50%

MasterControl vendor-reported reduction in Fagron deviation times at implemented facilities

02

Introduction and Industry Background

Biotechnology and life-sciences companies operate in some of the most highly regulated global environments. Bringing new biologics, pharmaceuticals, or medical devices to market demands rigorous quality management to ensure product efficacy and patient safety ([20]). Regulatory agencies require documented processes and controls: for example, the FDA’s 21 CFR Part 820 (medical device QMS regulation) and Part 11 (electronic record/sig rules), and international standards like ISO 13485 for medical device QMS. FDA’s QMSR, effective February 2, 2026, incorporates ISO 13485:2016 by reference for applicable medical-device manufacturers ([21]), forcing further harmonization of digital quality practices. Embedding compliance into daily operations is therefore critical. An effective QMS (Quality Management System) is understood as “a structured framework [that] helps organizations manage their documentation and processes to ensure the quality of their products” ([20]). Historically, QMS tasks were handled with paper logs and spreadsheets, but modern biotech firms increasingly digitize quality via eQMS platforms, automating approvals, workflows, and record-keeping ([20]) ([22]).

DataIntelo estimates that the global Quality Management Systems for Life Sciences market was about US$2.81 billion in 2024 and is projected to grow at ~9.7% CAGR to US$6.54 billion by 2033 ([23]). This expansion is driven by rising regulatory scrutiny, complex global supply chains, and demand for faster development cycles. North America leads adoption (≈US$1.13B in 2024) due to its mature biotech sector and stringent regulations ([24]), but Asia–Pacific is the fastest-growing region reflecting burgeoning biotech hubs ([24]).

In summary, eQMS solutions are at the heart of biotech quality strategy. They bring features like document version control, training records, CAPA tracking, audit management, and supplier oversight into a unified digital framework. This report examines three life-sciences eQMS comparators and an adjacent-industry platform – TrackWise, MasterControl, Qualio, and QualityOne – evaluating how each addresses biotech companies’ needs. We cover their historical context, functionality, case examples, and future trajectories, with an emphasis on evidence (market data, case outcomes, user reviews) to provide an objective comparison.

04

TrackWise (Honeywell Life Sciences)

Overview

Originally developed by Sparta Systems and acquired by Honeywell in 2020 ([28]) ([29]), TrackWise is positioned as an enterprise-grade EQMS. Honeywell markets TrackWise Digital (cloud on Salesforce) alongside its legacy on-premises TrackWise platform ([1]) ([29]). Companies frequently turn to TrackWise for its proven pedigree: “TrackWise is the world’s most widely used QMS software” according to the vendor ([7]). It has a 30-year history of deployment in the life-sciences (pharma, biotech, medical devices) and other regulated industries.

The system is designed for very large, complex operations. Its capabilities include full workflow management for deviations, complaints, CAPAs, change control, audit findings, and supplier issues, all tracked in a highly configurable rules-based engine ([30]) ([8]). A hallmark of TrackWise is its extensibility: companies can tailor forms and routing logic to fit intricate business rules, supporting multiple factories, geographies, and subsidiaries. Notably, TrackWise now touts advanced AI features (e.g. pattern detection in CAPA trends and natural-language agents) to push from reactive quality to a more proactive model ([1]) ([8]). It also claims to centralize all quality data (from documents to training records) into one platform ([31]), simplifying audit readiness.

Deployment and Technology

TrackWise offers both on-premise and cloud (Salesforce-based SaaS) editions ([16]). The cloud version provides mobility and easier scaling, though many large firms have multi-year on-prem installations as well. Because it is highly configurable, implementation planning should include assurance for the intended use ([10]). Daily administration is usually handled by a quality IT team, rather than by casual users. The interface has been praised as “intuitive and easy-to-use” for organizers of quality tasks ([32]), but the underlying setup is complex. TrackWise’s foundation on the Salesforce platform ensures strong security and global availability ([16]).

Regulatory and Quality Capabilities

Evaluate the product’s record controls and workflows against your applicable requirements. For software used in medical-device production or quality management, FDA’s software-assurance guidance describes assurance based on risk and intended use. Request evidence for the exact product, edition, configuration and release; a feature list does not establish organizational compliance.

Strengths and Differentiators

TrackWise’s configurability is relevant to organizations evaluating workflows across sites and product lines. Honeywell describes TrackWise AI as supporting AI-augmented quality processes. Test the required workflows and analytics in a scoped demonstration rather than infer customer outcomes from another vendor’s marketing.

Evaluation considerations

Request a scoped project plan, total-cost quote and demonstration of the workflows that quality specialists and occasional users will perform. Define configuration and assurance responsibilities for the selected edition Computer Software Assurance for Production and Quality Management System Software — FDA, February 2026.

Use Case – TrackWise in Biotech (Hypothetical)

A multisite biotech could evaluate document control and CAPA workflows for shared oversight of manufacturing facilities. This is an illustrative procurement scenario, not a documented customer implementation, speaker quotation or measured outcome.

“

Vendor case studies and testimonials provide useful examples, but their results should remain tied to the named implementation, measured activity and reported scope. They are not controlled comparisons or guarantees for a future deployment.

05

MasterControl Quality Excellence

Overview

MasterControl Quality Excellence (often simply “MasterControl Qx”) is a widely adopted integrated eQMS suite from a U.S.-based company. Founded in the early 1990s, MasterControl has focused on the life sciences market, now serving over 1,100 customers globally ([2]). MasterControl documents cloud SaaS packages MasterControl pricing. Verify any alternative hosting arrangement directly with the vendor. Its ethos is quality at the “source” of product development, spanning from product design through manufacturing and post-market. In the MasterControl suite, Quality Excellence is complemented by modules for document control, training, risk, audit, and even lean manufacturing (e.g. electronic batch records), yielding an end-to-end quality-manufacturing solution.

Key Features

MasterControl covers the core QMS sub-systems that FDA regulates. It provides workflow-based Deviation and CAPA management with configurable forms and routing logic ([11]). Its Document Management module enforces electronic signatures and version control, enabling rapid approval cycles of SOPs and specifications. Training records are linked to controlled documents, ensuring personnel are trained on the latest procedures. MasterControl also includes robust Audit Management (audit planning, findings tracking, closure tasks) and built-in Risk Management where risks identified in one process (like a CAPA) feed back into system-wide reports.

The platform shines in configurability and integration. Administrators can tailor workflows for complex processes, such as managing concurrent CAPAs across multiple product lines or hierarchies of distributors. MasterControl’s February 18, 2025 announcement documents Document Summarizer, Document Translator and Exam Generator with human review before acceptance MasterControl Announces General Availability of AI-Powered Document Summarizer. Reporting is a strength – the Insights portal offers customizable dashboards and data queries across all quality activities. Moreover, MasterControl is built to integrate: the vendor explicitly notes easy connectivity to ERP, CRM, MES and other enterprise systems with enterprise connectors ([13]) ([19]). This allows, for instance, automatically triggering a CAPA from an out-of-spec measurement in a manufacturing system, or pulling customer complaint data directly from CRM.

Implementation and Use

Define the implementation scope, process mapping, configuration, training and assurance deliverables before setting a schedule. MasterControl’s pricing documentation describes packages for emerging companies and enterprises, including pre-configured and pre-validated offerings. For applicable medical-device production/QMS uses, FDA guidance describes risk-based assurance for the intended use. Review supplier evidence and determine additional assurance activities for the actual deployment based on the actual implementation scope.

Once in production, MasterControl aims to serve both quality and cross-functional users. For example, manufacturing engineers may use it for managing change controls, whereas quality auditors use it to track oversight. The interface is menu-driven and form-based; many users find that mastering its screens requires initial training (especially those used to informal Excel tracking) ([10]). But once trained, teams benefit from end-to-end visibility: all quality records reside in one system (reports, spreadsheets, and binder-push are eliminated).

Strengths

MasterControl is regarded as feature-rich and robust for large-scale regulated enterprises. Its strength is in handling complexity: a single deployment can span dozens of sites and multiple quality standards. Customers often cite MasterControl’s extensive document control and audit-trail mechanisms as critical for passing inspections. The product tour on its website emphasizes “making quality a competitive differentiator” ([33]), reflecting its aim to engage all departments with quality-driven processes. In its Fagron case study, the vendor reports a 100% improvement in right-first-time metrics and a 50% reduction in deviation times at implemented manufacturing facilities. These are vendor-reported improvements, not a final 100% pass rate.

MasterControl provides packaged validation support; confirm the included tools, services and additional customer assurance work in the selected package MasterControl pricing.

Evaluation considerations

Request a demonstration of the required workflows and role-specific screens. Define the selected modules, users, implementation services and assurance responsibilities before comparing cost and effort MasterControl pricing.

Use Case – MasterControl in Biotech

The Fagron vendor case study reports a 100% improvement in right-first-time metrics and a 50% reduction in deviation times at implemented manufacturing facilities. It describes rollout in several U.S. sites and seven European sites. Its account of document sharing and training efficiencies applies to that implementation scope; Fagron’s 66-location footprint is not evidence that every site had deployed the system or achieved those results.

06

Qualio

Overview

Qualio is a modern cloud-based eQMS launched to serve growing life-sciences companies. Founded in 2012 according to founder Robert Fenton Announcing Qualio's $50M Series B Funding Round, Qualio was built specifically for biotech, medical-device, and pharmaceutical clients, particularly startups and SMEs. The company notes that “life science companies of all sizes use Qualio” to embed GxP and FDA/ISO compliance into their processes ([34]). Qualio’s target user sees quality software as a utility, not a burdensome project: its mantra is to make quality workflows “fast, configurable, and intuitive.” As a pure SaaS platform (no on-prem option), Qualio appeals to companies that want quick time-to-value without heavy IT resources.

Key Features

Qualio provides the essential QMS modules in one integrated suite. These include Document Management (authoring, review/approve workflows, version history, and electronic signatures) ([18]); Training Management (linking content to employee training requirements) ([18]); Quality Events (simple CAPA, deviation, complaint handling workflows); Supplier/Change Control modules; and Risk Management tools. It also offers built-in analytics and dashboards to monitor these processes, though its analytics are relatively streamlined.

Qualio provides workflows and templates intended to support regulated quality processes Qualio plans and pricing. Assess the applicable requirements for your records and procedures using FDA’s Part 11 guidance rather than treating configuration or vendor alignment language as a compliance determination.

User Experience and Implementation

An oft-cited Qualio advantage is its usability and speed of rollout. Qualio’s current vendor estimate is that most customers go live in 30–60 days with the right preparationQualio plans and pricing. For example, one client testimonial reports, “I contacted Qualio in November ... we had our ISO 13485 certification by July” of the following year ([5]). Qualio’s cloud nature means updates and maintenance are handled by the vendor, further reducing effort for customers. The interface is clean and web-native, using dashboards, drag-and-drop forms, and Slack/email notifications. The vendor emphasizes “no-code” configuration, allowing internal quality teams to create or modify workflows without developer help.

However, to ensure compliance, some initial effort is still required. Plan assurance for the intended use and set up access controls (e.g. user accounts and permissions); for applicable medical-device production/QMS uses, follow a risk-based assurance approach Computer Software Assurance for Production and Quality Management System Software — FDA, February 2026. Qualio provides validation documentation and can assist with mapping processes, but the responsibility rests with the user. In practice, companies find Qualio’s support team responsive: many reviews note that Qualio’s customer success squads help drive adoption through training webinars and onboarding guides.

Strengths

For smaller biotech firms, Qualio’s biggest strengths are its agility and lower cost of entry. It brings together all core QMS functions so companies no longer manage separate Google Docs, spreadsheets, or local intranets for documents and CAPAs. Being cloud-based, it has no hardware or large capital outlay. The platform’s configurability strikes a balance: while it cannot be reprogrammed, users can create custom fields and event forms, and decide which processes to automate. Its small-company focus means that customer support and community are geared to the DNA of startups – fast response, iterative feedback, and the ability to escalate product requests.

Evaluation considerations

Test required reporting, document editing, integrations, permissions and quality-event workflows. Confirm package inclusions and additional fees in the vendor proposal Qualio plans and pricing.

Use Case – Qualio in Biotech

In Qualio’s customer testimonial, Karen Hue, Head of Quality & GxP Compliance at 30 Technology, says the company contacted Qualio in November, went live in mid-December, had all users in by January, and received ISO 13485 certification by July. This is a named customer’s vendor-hosted account. Assess system go-live and certification as separate milestones. Do not generalize its timing to other deployments.

AI capabilities

Qualio’s July 5, 2024 AI announcement describes document change summaries, training assessment generation and document editing. The current pricing page lists AI-powered gap analysis. Confirm the contracted features and release availability in a demonstration.

07

QualityOne (Veeva): Adjacent-Industry Comparator

Overview

QualityOne is Veeva’s quality platform for consumer packaged goods, food and beverage, and chemicals. It runs on Veeva Vault, but must be distinguished from life-sciences Quality Cloud. Veeva’s April 16, 2018 announcement says it expanded into other regulated manufacturing markets with QualityOne in 2016.

Documented applications

QualityOne’s product page describes quality assurance processes, HACCP food safety, validation, documentation, training and lab workflows. It documents open APIs for ERP, PLM and MES data exchange and controlled external collaboration. Confirm the exact applications, data flows, access controls and contracted functionality for any proposed integration; sharing a platform does not establish a ready-made connection to clinical, regulatory or CRM applications.

AI

QualityOne’s own product documentation describes Vault AI in its platform and quality applications. Evaluate the named agents for the selected applications and release rather than transfer capabilities from life-sciences Quality Cloud marketing.

Implementation and procurement

QualityOne applications are available separately. Define the selected applications, implementation services, assurance work and site scope before comparing proposals. Compare costs only for matched user, site and application scopes.

Biotech relevance

Treat QualityOne as a contextual comparator for adjacent manufacturing industries. For a biopharma or MedTech evaluation, separately assess Veeva Quality Cloud, which Veeva positions for those industries. Request evidence for your own regulatory requirements and intended use; neither product identity nor standard workflows establish FDA/ISO compliance.

Primary product and procurement documentation; separate life-sciences Quality Cloud documentation; 2018 expansion announcement.

08

Comparative Analysis and Discussion

The four eQMS solutions exhibit distinct emphases even as they overlap in core functionality. TrackWise and MasterControl represent the established, broad-spectrum QMS tools. Evaluate their workflow scope against the organization’s requirements. They differ in that TrackWise is now deeply entwined with Honeywell’s process automation portfolio, and emphasizes AI and integration with manufacturing systems ([1]) ([8]), whereas MasterControl accents configurability across quality and manufacturing separation (MasterControl includes MES and asset management modules). In routine use, QualityOne and Qualio stand apart as more niche/cloud offerings: Qualio targets smaller life-science innovators and is valued for speed and simplicity ([5]) ([6]), whereas QualityOne (Vault) targets large multi-product manufacturers and leverages Veeva’s enterprise platform for unified quality processes ([35]) ([17]).

Feature Set

All four provide document control with revision and e-signatures, CAPA tracking, training management, and audit scheduling. Assess audit-trail and electronic-signature controls for the actual records and processes using FDA’s Part 11 guidance. Differences arise in depth: TrackWise and MasterControl include extensive deviation and change-control modules (handling multiple deviation types, technical review steps, quality boards, etc.), while Qualio’s CAPA is simpler and more streamlined. QualityOne also includes change and CAPA modules, but with the added capability to link these to other Vault records (e.g. connecting a CAPA to a nonconformance in a production report).

On analytics, compare demonstrated functions rather than rank products from marketing claims. Honeywell documents AI-augmented quality processes TrackWise AI for Life Sciences Quality Management — Honeywell; MasterControl documents Document Summarizer, Document Translator and Exam Generator MasterControl Announces General Availability of AI-Powered Document Summarizer; and Qualio’s July 2024 announcement describes document editing, change summaries and training assessments Faster, streamlined quality processes powered by AI in Qualio. For QualityOne, use its own product documentation Quality Management Solutions — Veeva QualityOne. Confirm available functions, human review, licensing and release scope.

Deployment Model

Confirm the supported hosting model and migration requirements for the exact product and edition. Qualio’s vendor estimate is that most prepared customers go live in 30–60 days Qualio plans and pricing. Do not compare that estimate with an unscoped enterprise implementation or with time to certification.

Validation and Compliance

For software used in medical-device production or quality management, FDA guidance describes risk-based assurance for intended use. Assess supplier evidence and the deployment’s configuration, integrations and workflows to determine additional assurance work. MasterControl documents packages that include pre-configured/pre-validated options MasterControl pricing. Do not infer a universal IQ/OQ/PQ recipe or inherent regulatory compliance for any vendor from these offerings.

Market Perspective

Review recency, sample size, product identity and relevant workflows before using customer ratings in procurement. An average star score is not evidence that serious product issues are absent. Compare direct demonstrations and reference discussions alongside review evidence.

Business Models & Pricing

Qualio offers tailored annual recurring subscriptions Qualio plans and pricing. An implementation fee applies; plans include edit users and unlimited basic users. Obtain comparable proposals for the required users, modules, sites, integrations, services and assurance work. QualityOne applications are available separately Quality Management Solutions — Veeva QualityOne. Compare matched scopes before drawing cost conclusions.

Security and Data Integrity

Define the required record controls and request evidence for the actual configuration. Evaluate access permissions, audit trails, electronic signatures, record retention, backups, data migration, training and operating procedures. Use FDA’s Part 11 scope guidance to determine relevant records and requirements. A shared cloud foundation or a high review score should not be used to assure inspection acceptance.

F.01
Enterprise workflows and growing-company needs
TrackWise and MasterControlComplex enterprise workflows
  • TrackWise supports configurable workflows across factories, geographies and subsidiaries.
  • MasterControl combines quality management and manufacturing execution in an integrated suite.
QualioGrowing life-sciences companies
  • Pure SaaS delivery appeals to companies seeking quick time-to-value without heavy IT resources.
  • Quality teams can configure workflows without developer help; test required reporting, integrations and permissions.

Suitability depends on workflow fit and implementation scope. QualityOne is an adjacent-industry comparator; Veeva Quality Cloud is a separate life-sciences offering.

09

Case Studies and Evidence

This section highlights illustrative examples of each solution in real biotech or related contexts.

  • MasterControl – Fagron (Pharmaceuticals). In its Fagron case study, MasterControl reports a 100% improvement in right-first-time metrics and a 50% reduction in deviation times at implemented manufacturing facilities. The case describes several U.S. sites and seven European sites. These vendor-reported results are relative improvements within the implemented scope; they do not establish a final 100% yield or deployment across all 66 locations.

  • Qualio – 30 Technology (MedTech). In Qualio’s vendor-hosted testimonial, Karen Hue describes contacting Qualio in November, going live in mid-December, having all users in by January and receiving ISO 13485 certification by July. Assess system go-live and certification as separate milestones.

  • TrackWise – Large Biotech Example. While few public case studies name TrackWise in biotech, the system’s penetration implies many. For a hypothetical example, consider a global biotech firm with multiple manufacturing sites developing a novel biologic. By deploying TrackWise Digital, the CMC (Chemistry, Manufacturing & Controls) division could consolidate its CAPA and validation records across sites. For instance, a quality issue identified at Site A could automatically trigger a CAPA sequence visible to Site B, preventing duplicate investigations. The built-in analytics could alert management if a particular supplier is causing repeated deviations. TrackWise’s adoption of AI (QualityWise) could further help by, say, recommending corrective actions based on historical data. Although we lack a public citation for this hypothetical, it aligns with TrackWise’s claimed capabilities: “companies trust TrackWise to help them get safer products to market faster, while minimizing risk” ([7]).

  • QualityOne – Procurement Scenario (Hypothetical). A manufacturer in QualityOne’s documented industries could evaluate quality assurance, food safety, documentation, training and lab workflows Quality Management Solutions — Veeva QualityOne. This is a hypothetical evaluation scenario; no customer result is asserted. Veeva’s life-sciences Quality Cloud should be assessed separately for biopharma or MedTech requirements.

  • Cross-vendor Regulatory Assessment. QMSR applies to finished-device manufacturers intending to commercially distribute medical devices Quality Management System Regulation (QMSR) — FDA. For relevant software used in device production or quality management, FDA guidance describes assurance based on risk and intended use. Assess the chosen configuration and customer procedures; templates and marketing do not establish regulatory sufficiency for all four platforms.

Vendor case studies and testimonials provide useful examples, but their results should remain tied to the named implementation, measured activity and reported scope. They are not controlled comparisons or guarantees for a future deployment.

F.02
30 Technology's Qualio customer milestones
  1. NovemberInitial contact

    30 Technology contacted Qualio in November.

  2. DecemberSystem go-live

    30 Technology went live in mid-December.

  3. JanuaryAll users in

    All users were in the system by January.

  4. JulyISO 13485 certification

    30 Technology received ISO 13485 certification by July. Assess certification and system go-live as separate milestones.

10

Data Analysis

Market and Growth Data

  • Market Size and Forecast: Market research estimates for the life-sciences QMS segment show robust growth. DataIntelo estimates the global market at $2.81B in 2024 and forecasts $6.54B by 2033 ([23]) – a publisher forecast using a 9.7% CAGR, rather than an observed market total. These figures underscore the increasing digitization of quality processes. The software component dominates this market, as firms invest in cloud platforms over manual services ([23]).

  • Regional Distribution: DataIntelo estimates that over 40% of the 2024 market was in North America (≈$1.13B) ([23]) ([24]), reflecting its high biotech/pharma concentration and regulatory rigor. Europe also holds a large share aided by both pharma presence and unified EU standards. Asia-Pacific is a fast-growing region, with rising biotech sectors in China, India, and Southeast Asia ([24]). This trend benefits cloud-native eQMS vendors, as many Asian firms leapfrog to modern SaaS solutions.

  • Review Evidence: Check the review platform, observation date, product identity and sample size. Do not use aggregate star ratings to infer the absence of major problems or to treat vendors with unequal review populations as interchangeable.

  • Contract Value: Qualio’s official pricing page describes a tailored annual recurring subscription, an implementation fee, included edit users and unlimited basic users Qualio plans and pricing. Obtain like-for-like proposals for the selected modules, users, sites, integrations and services before comparing total costs. Include implementation and ongoing service costs in each proposal.

Features and Capabilities

We have summarized key feature differences in Table 1. Analysis of cited feature lists yields these observations:

F.03
Life-sciences QMS market: estimate and forecastUS$ billions
Source: DataIntelo
11

Future Directions and Implications

Looking ahead, biotech quality management will evolve on several fronts:

  • Increased Automation and AI: The trend toward Quality 4.0 will accelerate. As noted, digital transformation experts predict that next-generation QMS will leverage AI for not just analysis but autonomy (e.g. AI suggesting CAPA actions or predicting nonconformances). Vendors are already integrating AI: TrackWise and Veeva have pioneered AI agents ([1]) ([36]). We expect to see deeper machine learning (e.g. anomaly detection in process data streams driving CAPA), as well as natural language processing to auto-classify documentation. Biotech firms should anticipate that future eQMS releases will incorporate more of these capabilities, reducing manual work.

  • Regulatory Changes: FDA’s QMSR became effective February 2, 2026, for applicable medical-device manufacturers Quality Management System Regulation (QMSR) — FDA. Plan review of applicable requirements, workflows, assurance evidence and customer procedures as regulations evolve; do not assume compliance out of the box or generalize medical-device requirements to every life-sciences operation.

  • Integration with Clinical and R&D Systems: A key future implication is tighter integration of quality data with other enterprise data sources. For biotech, this could mean linking eQMS with LIMS (Lab Information), EDMS (Engineering Docs), CTMS (Clinical Trial) and ERP (Supply Chain). MasterControl is already building these interfaces (and even packaging CAPA with LIMS information), while Veeva’s vault-centric model naturally connects quality docs with clinical and regulatory records. Ask each vendor to distinguish released integrations from roadmap proposals. Ultimately, the “system of record” for product quality will become more networked. Buyers should evaluate not only standalone features but how an eQMS will fit into their IT architecture five years from now.

  • Scalability and Cloud/SaaS: Cloud delivery will increasingly dominate. Even for highly sensitive data, hybrid models (e.g. trackwise on Salesforce devoted to one cloud tenancy) will make remote audits and distributed teams easier. We expect vendors to push further into microservices and API-first designs, enabling micro-integrations (e.g. sending a CAPA status to a custom mobile app). SaaS eQMS also facilitate faster innovation cycles: buyers should confirm the release cadence, support window and assurance responsibilities for the selected edition. The competitive advantage will lie in agility.

  • User Experience and Adoption: Another trend is focus on “consumer-grade” interfaces. Even enterprise apps now need to be as intuitive as popular SaaS tools. Qualio has led here, but others are catching up. TrackWise and MasterControl are modernizing UIs (moving from legacy screens to web dashboards). Investments in mobile apps (for out-of-lab workers) and multilingual support will grow. For biotech, where staff ranges from PhDs to QC technicians, ease of use is crucial; we foresee increasing use of wizards and guided workflows in these systems.

  • Data Analytics and Continuous Improvement: Beyond compliance, eQMS will be used for quality intelligence. Advanced analytics engines will mine historical CAPA and batch data to identify systemic risks (e.g. a particular raw material linked to multiple complaints). More startups in quality data analytics may emerge (akin to how business intelligence has shaken up financial software). Already, vendors hint at predictive quality modules. Biotech companies adopting eQMS should plan for leveraging these insights to drive real continuous improvement programs.

Overall, the evidence and expert commentary suggest that investing in a modern eQMS is not just a compliance checkbox but a strategic move. As one Veeva strategist put it, digital QMS “is integral to improving pharmaceutical processes across the industry” ([37]). The four solutions studied here will continue to evolve: Honeywell/TrackWise and MasterControl (as large incumbents) will likely acquire or add features to cover new trends (e.g. IoT, AI). Qualio’s existing AI announcement already covers document editing, change summaries and training assessments Faster, streamlined quality processes powered by AI in Qualio. Future capabilities still require release-specific verification. Evaluate Veeva’s life-sciences Quality Cloud separately from QualityOne; Veeva positions Quality Cloud for biopharma, MedTech and contract manufacturing Biopharmaceutical Quality Management Software — Veeva.

12

Conclusion

Biotech organizations face a critical decision in selecting an eQMS, as it affects both compliance and speed-to-market. This comprehensive comparison has shown that no one solution is categorically “best”; rather, suitability depends on the organization’s size, structure, and priorities.

  • Large enterprises with complex global operations often find TrackWise or MasterControl more fitting. These systems can handle vast, intricate workflows and can be tailored to strict regulatory regimes ([31]) ([12]). MasterControl’s integration with manufacturing execution and broad customer base ([2]) ([13]) make it attractive to big pharma. TrackWise’s scalability and recent AI investments ([1]) ([31]) appeal to established biologics companies.

  • Small to mid-sized biotech/medtech companies should include Qualio in their evaluation and test their required workflows. Its vendor estimate is that most prepared customers go live in 30–60 days Qualio plans and pricing. Assess scope and operating needs before inferring a deployment or budget advantage.

  • Manufacturers in consumer packaged goods, food and beverage, or chemicals may evaluate QualityOne (Veeva) for its documented quality assurance, documentation, training, food safety and lab workflows Quality Management Solutions — Veeva QualityOne. Biopharma and MedTech buyers should separately assess Veeva Quality Cloud. Confirm application-specific integrations and procurement scope; a shared platform is not proof of clinical/CRM/regulatory integration.

Buyers should assess requirements for the actual manufacturer, processes and records. For applicable medical-device production/QMS software, FDA’s guidance describes assurance based on risk and intended use. Use FDA’s Part 11 scope guidance to assess electronic records. Evaluate configuration, supplier evidence, procedures, training and data-integrity controls; the article does not establish inherent compliance or guaranteed audit acceptance for any platform.

The choice among TrackWise, MasterControl and Qualio should follow demonstrated workflow fit, a scoped implementation plan and comparable commercial proposals. Keep QualityOne’s adjacent-industry scope distinct from Veeva’s life-sciences Quality Cloud. Use the documented cases as implementation-specific evidence rather than guarantees of outcomes for another organization.

The publisher

About IntuitionLabs

Build practical AI for pharma and biotech with IntuitionLabs. We help life-science teams turn complex information and workflows into useful software, governed knowledge systems and AI tools.

IntuitionLabs is an AI consulting, custom software development and data engineering firm serving pharmaceutical, biotechnology, medical-device and other life-science organizations. We work with clinical, regulatory, medical-affairs, commercial, quality and IT teams to connect technology decisions with the work people need to accomplish.

AI consulting and adoption

Our AI enablement services cover readiness assessments, use-case selection, governance and policies, team workshops, adoption measurement and ongoing advisory support. We help organizations structure the information layer behind AI: source material, context, permissions and maintained knowledge that make generated answers useful and reviewable. Private LLM inference and hosted AI options support teams evaluating how to operate AI with appropriate control over their data and infrastructure.

Software, data and life-science workflows

IntuitionLabs develops custom software for pharma and biotech, integrates enterprise systems, and builds data engineering and business intelligence solutions. Areas of focus include AI agents, regulatory research, medical writing, medical affairs, CMC information, competitive intelligence and clinical-document workflows. Our eTMF intelligence work includes cross-system reconciliation and inspection-readiness support.

Enterprise platforms and regulated delivery

We provide Veeva services, application support, managed services, integrations and custom applications, alongside enterprise content work involving platforms such as Egnyte. For regulated workflows, our services include GxP enablement, computer-system validation and software development addressing 21 CFR Part 11 requirements. The applicable controls, validation responsibilities and acceptance criteria are defined for each engagement.

Work with IntuitionLabs

Explore AI enablement, pharma and biotech software development, data engineering and BI, and Veeva services. Contact IntuitionLabs to discuss your workflow, information sources and implementation needs.

IntuitionLabs publishes educational research to help life-science teams make informed technology decisions. Coverage of a product or organization does not imply a client relationship, endorsement or partnership.

Sources / 37
Adrien Laurent

Need Expert Guidance on This Topic?

Let's discuss how IntuitionLabs can help you navigate the challenges covered in this article.

I'm Adrien Laurent, Founder & CEO of IntuitionLabs. With 25+ years of experience in enterprise software development, I specialize in creating custom AI solutions for the pharmaceutical and life science industries.

Disclaimer

The information contained in this document is provided for educational and informational purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information contained herein. Any reliance you place on such information is strictly at your own risk. In no event will IntuitionLabs.ai or its representatives be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from the use of information presented in this document. This document may contain content generated with the assistance of artificial intelligence technologies. AI-generated content may contain errors, omissions, or inaccuracies. Readers are advised to independently verify any critical information before acting upon it. All product names, logos, brands, trademarks, and registered trademarks mentioned in this document are the property of their respective owners. All company, product, and service names used in this document are for identification purposes only. Use of these names, logos, trademarks, and brands does not imply endorsement by the respective trademark holders. IntuitionLabs.ai is an AI software development company specializing in helping life-science companies implement and leverage artificial intelligence solutions. Founded in 2023 by Adrien Laurent and based in San Jose, California. This document does not constitute professional or legal advice. For specific guidance related to your business needs, please consult with appropriate qualified professionals.

Related Articles

Need help with AI?

© 2026 IntuitionLabs. All rights reserved.